Migraine drug-specific coverage maximum lowers costs

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.428, 2003-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dermatological reactions to antiretrovirals extend beyond drug-specific reactions

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 4, 2008-04 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences

By Rappange David R.  

PharmacoEconomics, Vol. 27, Iss. 12, 2009-12 ,pp. : 1031-1044

Adis International

Access to resources Recommend Favorite

IBS lowers QOL, increases costs in the UK

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Amiodarone lowers costs for atrial fibrillation in Canada

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Varicella vaccination lowers hospitalisations, costs in the US

By  

Inpharma, Vol. 1, Iss. 1464, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite